Viemed Healthcare, Inc. (VMD) Misses Q2 EPS by 5c ; Offers Guidance

Viemed Healthcare, Inc. (NASDAQ: VMD) reported Q2 EPS of $0.07, $0.05 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $78.1 million versus the consensus estimate of $78 million.

FY 2026 Outlook:-

Net revenue is now expected to be in the range of $314 million to $320 million vs consensus $317.3 million.

For earnings history and earnings-related data on Viemed Healthcare, Inc. (VMD) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• AstraZeneca's camizestrant fails primary endpoint in breast cancer trial
• Boeing wins $13.4 billion contract modification from US military